PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.790
+0.080 (4.68%)
Nov 21, 2024, 3:02 PM EST - Market open

PharmaCyte Biotech Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
13.75M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 2024---
Apr 30, 2023---
Apr 30, 2022---
Apr 30, 2021---
Apr 30, 2020---
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro
Apr 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cosmos Health 56.04M
Psychemedics 20.26M
Ekso Bionics Holdings 17.68M
Vivos Therapeutics 14.58M
Can-Fite BioPharma 667.00K
Traws Pharma 226.00K
Revenue Rankings